BioSpace News Archive

Ross to play an instrumental role in the development of the company’s strategic plans to bring non-addictive pain medications to market

CVRx, Inc., a private medical device company, announced today that its BeAT-HF phase III randomized clinical trial results were published in the Journal of the American College of Cardiology (“JACC”)

Evaxion Biotech, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today that it has appointed Kim Bjoernstrup as Chairman of its Board of Directors.

Proscia®, a leading provider of AI-enabled digital pathology solutions, is collaborating with Royal Philips to advance an open ecosystem that helps laboratories accelerate and scale digital pathology adoption.

Laboratory testing completed at the Tropical Infectious Diseases Research and Education Center (TIDREC) at the University of Malaya, Malaysia, has confirmed the effectiveness of BETADINE® Gargle and Mouthwash against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease.

Oncopeptides AB (publ) (“Oncopeptides”) (Nasdaq Stockholm: ONCO) announces that the Board of Directors has appointed Marty J Duvall as Chief Executive Officer, CEO. Marty J Duvall replaces Jakob Lindberg who has been CEO since the restart of the company in 2011.

During June, Calliditas Therapeutics AB (publ) has issued 9,230,770 common shares as a result of the initial public offering on The Nasdaq Global Select Market in the United States and concurrent private placement of common shares to certain qualified investors in Europe and certain other jurisdictions outside of the United States.

SWORD Health, a digital musculoskeletal and pulmonary therapy provider, today announced the appointment of industry paragon Brian Marcotte to lead their Client Advisory Board.

Enzo Biochem, Inc., a leading biosciences and diagnostic company, and Farmingdale State College announced they are partnering to provide molecular and antibody testing for COVID-19 to the campus community as the college reopens this summer and begins classes in the fall.

Flagship Biosciences, providers of expert tissue data insights, today announced the launch of a new clinical diagnostics immuno-oncology service, TissueInsight.